Mi-thos® Transcatheter Mitral Valve Replacement Study

Recruiting now · Not applicable

Conditions studied: Mitral Valve Regurgitation

In brief

To evaluate the safety and performance of the Mi-thos® Mitral Heart Valve with the Mi-thos® Transcatheter Delivery System.

Key facts

Study ID

NCT04195984

Run by

Shanghai NewMed Medical Co., Ltd.

People needed

122

Starts

2021-03-25

Expected to finish

2027-01-01

Last updated by the study team

2025-02-13

Who can join

Age: 65 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Severe mitral valve regurgitation ≥ 3+;
• High surgical risk fot open mitral valve surgery;
• Age ≥ 65 years old;
• Life expectancy > 12 months;
• As assessed by multidisciplinary cardiac team, patients who are not eligible for surgery;
• Patients sign an informed consent form.

You may not qualify if…

• Previous cardiac mitral valve surgery;
• Active infections requiring antibiotic therapy;
• Clinically significant untreated Coronary Artery Disease (CAD);
• Pulmonary hypertension （Pulmonary systolic pressure > 70 mmHg）;
• Patients with severe right heart failure;
• Left ventricular ejection fraction <25%;
• Diagnosis of hypertrophic cardiomyopathy, restrictive cardiomyopathy, constrictive pericarditis;
• Dialysis patient;
• Patients with severe coagulopathy;
• Patients with contraindications to anticoagulant drugs;
• Patients with stroke or transient ischemic within 30 days;
• Echocardiography found any intracardiac mass, left ventricle or atrial thrombus;
• Patients who require surgery or interventional therapy for other valvular lesions;
• Patients with severe macrovascular disease requiring surgical treatment;
• Patients with more than 70% of carotid stenosis;
• To be allergic to contrast agents, nickel-titanium memory alloys or bovine-derived products;
• Patients with severe neurological disorders affecting cognitive ability;
• Patients with severe thoracic deformities.

Where it is running

• Fuwai hospital — Beijing, Beijing Municipality, China (enrolling)
• Zhongshan Hospital — Shanghai, Shanghai Municipality, China (enrolling)
• Xijing hospital — Xi’an, Shanxi, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.